MIT conference reveals the power of using artificial intelligence to discover new drugs
Inaugural AI Powered Drug Discovery and Manufacturing Conference drew pharmaceutical companies, government regulators, and pioneering drug researchers.
Inaugural AI Powered Drug Discovery and Manufacturing Conference drew pharmaceutical companies, government regulators, and pioneering drug researchers.
CSAIL's Conduct-A-Bot system uses muscle signals to cue a drone’s movement, enabling more natural human-robot communication.
Report offers guidelines to help prevent viruses from tainting biopharmaceutical drugs.
Studies of drug absorption in the small intestine could help researchers identify medicines that can be taken orally.
Microneedles made of silk-based material can target plant tissues for delivery of micronutrients, hormones, or genes.
Prestigious honor society announces more than 250 new members.
Based on crowdsourced data, app helps patients, EMTs, and physicians determine real-time availability of hospital resources.
Danagoulian and his research team developed a system that could greatly improve the process for verifying compliance of nuclear warheads.
MIT system cuts the energy required for training and running neural networks.
Professor of chemistry and IMES core member is recognized for his leadership and pioneering spirit.
When they encounter nutrient oases in the marine desert, marine bacteria release a gas involved in climate regulation.
The Audacious Project commitment will support the development of new classes of antibiotics to treat the world’s deadliest bacterial pathogens.
MIT’s vice president for research identifies three areas that show particular promise for climate action.
Manufacturability is key to producing a widely available, affordable vaccine.
Study finds specific cells in the lungs, nasal passages, and intestines that are more susceptible to infection.